Ocean Biomedical, Inc.
OCEA· OTC
OCEAOcean Biomedical, Inc.
Filed Aug 14, 2023 · 10-Q · 45 days after period end · 0001493152-23-028396
| Metric | Q2 2023 | Q2 2022 |
|---|---|---|
| Net Income | -$11.43M | -$184.93K |
| EPS Diluted | -$0.43 | -$0.31 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Ocean Biomedical, Inc. · CIK 1869974 · Engraved from SEC EDGAR
ended Jun 30, 2023 · filed Aug 14, 2023 · 45 d after period end
